Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS)
IMPRESS
1 other identifier
interventional
10
1 country
1
Brief Summary
A prospective study evaluating prone and supine positioning for radiation planning of spine Cyberknife radiotherapy treatment. Patients with tumours in which PTV coverage is compromised due to tumour geography, including posteriorly based lesions in the vertebral column and close proximity to organ at risk (other than the spinal cord).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 27, 2022
CompletedFirst Posted
Study publicly available on registry
February 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedFebruary 23, 2022
February 1, 2022
2.5 years
January 27, 2022
February 14, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
PTV isodose coverage
To compare the PTV coverage of radiotherapy plans delivered in prone and supine positions
Through study completion, an average of 1 year.
Secondary Outcomes (4)
Organs at risk dose
Immediate
Comfort scores
Immediate
CT and MRI registration
Immediate
Treatment time duration
Immediate
Study Arms (2)
Supine
ACTIVE COMPARATORPatients undergo supine setup and imaging for radiation planning
Prone
EXPERIMENTALPatients undergo prone setup and imaging for radiation planning
Interventions
Patients will undergo an additional CT scan acquisition at CT radiotherapy planning in order that all participating patients have a prone and supine CT scan available to compare radiation therapy plans.
Eligibility Criteria
You may qualify if:
- Patients undergoing Cyberknife treatment to spinal metastasis
- \>18 years of age
- Thoracic, lumbar and sacral spinal metastasis
- Patients suitable to undergo radiotherapy planning CT scans in the prone position (treating physician assessed as having spinal stability).
- All solid tumour types will be eligible
You may not qualify if:
- Primary spinal tumours
- Vertebral disease resulting in unstable spinal vertebrae
- Cervical tumours (patients will be unable to have a thermoplastic shell made for the prone position).
- Patients with significant pain on prone lying (to be assessed by physician prior to consent)
- Bilsky epidural score of 2 or greater (see appendix 1)
- Pre-existing musculoskeletal chronic back medical diagnoses that would preclude CT scanning in the prone position.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM2 5PY, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2022
First Posted
February 23, 2022
Study Start
July 1, 2020
Primary Completion
December 31, 2022
Study Completion
April 1, 2023
Last Updated
February 23, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share